IMR · ASX

Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (ASX:IMR)

AU$1.02

 0.07 (7.33%)
ASX:Live
20/12/2024 04:10:10 PM
HALO Price Momentum HALO Ords GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

IMR Overview

IMR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Neutral

Growth

Earnings

Neutral

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About IMR

Website

Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh

Telephone

1.952.818.8400

Address

400 Gateway Boulevard Burnsville, MN 55337

Description

Imricor Medical Systems, Inc. is a medical device company, which engages in the design, manufacture, and distribution of magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures. The firm offers the Advantage-MR EP Recorder/Stimulator system, an electrophysiology amplifier and recording system with integrated cardiac stimulator, Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter, and Vision-MR Dispersive Electrode, an ablation dispersive electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. The company was founded by Steven Wedan in 2006 and is headquartered in Burnsville, MN.

IMR Price Chart

Key Stats

Market Cap

AU$263.42M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.41 - 1.38

Trade Value (12mth)

US$15,660.00

1 week

-11.16%

1 month

1.6%

YTD

79.3%

1 year

79.3%

All time high

2.85

Key Fundamentals

EPS 3 yr Growth

32.00%

EBITDA Margin

%

Operating Cashflow

-$13m

Free Cash Flow Return

-221.80%

ROIC

-386.80%

Interest Coverage

-333.60

Quick Ratio

0.50

Other Data

Shares on Issue (Fully Dilluted)

191m

HALO Sector

Healthcare

Next Company Report Date

19-Feb-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

IMR Announcements

Latest Announcements

Date Announcements

28 November 24

Imricor Signs License Agreement with ADIS for Northstar

×

Imricor Signs License Agreement with ADIS for Northstar

27 November 24

Imricor Performs First Procedure in Switzerland

×

Imricor Performs First Procedure in Switzerland

17 October 24

NorthStar Update

×

NorthStar Update

16 October 24

Imricor Q3 CY24 Quarterly Activities Report and Appendix 4C

×

Imricor Q3 CY24 Quarterly Activities Report and Appendix 4C

16 October 24

Release from Voluntary Escrow

×

Release from Voluntary Escrow

14 October 24

Regulatory Update

×

Regulatory Update

10 October 24

Notification of cessation of securities - IMR

×

Notification of cessation of securities - IMR

09 October 24

Notification regarding unquoted securities - IMR

×

Notification regarding unquoted securities - IMR

25 September 24

Becoming a substantial holder

×

Becoming a substantial holder

06 September 24

Application for quotation of securities - IMR

×

Application for quotation of securities - IMR

06 September 24

Cleansing Notice

×

Cleansing Notice

29 August 24

Results of Meeting

×

Results of Meeting

28 August 24

Appendix 4D and Half Year Report & Accounts

×

Appendix 4D and Half Year Report & Accounts

28 August 24

Imricor releases Half Year Results for 1H 2024

×

Imricor releases Half Year Results for 1H 2024

28 August 24

H1 FY24 Results Investor Presentation

×

H1 FY24 Results Investor Presentation

13 August 24

Imricor Pauses TGA Process to Wait for 2nd Gen Catheter

×

Imricor Pauses TGA Process to Wait for 2nd Gen Catheter

08 August 24

FY24 1H Results Webinar Notification

×

FY24 1H Results Webinar Notification

08 August 24

Release from Voluntary Escrow

×

Release from Voluntary Escrow

08 August 24

Notice of Extraordinary General Meeting/Proxy Form

×

Notice of Extraordinary General Meeting/Proxy Form

07 August 24

First Patient Treatment in the U.S. in the VISABL-AFL Trial

×

First Patient Treatment in the U.S. in the VISABL-AFL Trial

06 August 24

Appendix 3X - Jeffrey Leighton

×

Appendix 3X - Jeffrey Leighton

31 July 24

Imricor Q2 CY24 Quarterly Activities Report and Appendix 4C

×

Imricor Q2 CY24 Quarterly Activities Report and Appendix 4C

31 July 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

26 July 24

Application for quotation of securities - IMR

×

Application for quotation of securities - IMR

26 July 24

Cleansing Notice

×

Cleansing Notice

IMR Fundamentals

Per Share Records

Historical data

Forecast data

USD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.15 -0.12 -0.14 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.15 -0.12 -0.14 Lock Lock Lock
     Growth % Lock Lock Lock Lock -33.4 21.0 -25.3 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.12 -0.10 -0.09 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.13 -0.11 -0.08 Lock Lock Lock
     Growth % Lock Lock Lock Lock -37.5 14.0 11.4 Lock Lock Lock
     Yield % Lock Lock Lock Lock -18.4 -45.4 -22.8 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.15 0.05 -0.05 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.15 0.05 -0.05 Lock Lock Lock
     Growth % Lock Lock Lock Lock -31.2 -68.3 -207.8 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 135 150 157 Lock Lock Lock
Basic m Lock Lock Lock Lock 135 150 157 Lock Lock Lock

Financial Records

Historical data

Forecast data

USD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -0.8 17.2 -24.6 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 18 16 16 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -2 -2 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -376.8 19.5 26.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -272.3 -187.1 -181.3 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 372 287 281 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -20 -17 -16 Lock Lock Lock
     Growth % Lock Lock Lock Lock -71.2 15.4 3.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2,810.7 -2,027.9 -2,598.4 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -20 -17 -17 Lock Lock Lock
     Growth % Lock Lock Lock Lock -69.4 14.8 2.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2,909.7 -2,115.2 -2,738.1 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -20 -17 -23 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -20 -17 -23 Lock Lock Lock
     Growth % Lock Lock Lock Lock -58.5 12.0 -30.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2,834.0 -2,127.0 -3,675.6 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -17 -17 -13 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -1 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 12 4 8 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -18 -17 -13 Lock Lock Lock
     Growth % Lock Lock Lock Lock -39.6 7.5 22.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -26.0 -20.5 -21.2 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 19 6 1 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 27 14 8 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 4 10 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -17 -1 10 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 4 6 17 Lock Lock Lock
Equity $m Lock Lock Lock Lock 23 8 -9 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 24 11 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -22.9 -53.1 -92.2 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -73.5 -126.7 -272.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -85.3 -226.1 265.7 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -73.2 -98.0 -247.7 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -72.8 -102.5 -386.8 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -64.5 -97.5 -221.8 Lock Lock Lock

Ratios Records

Historical data

Forecast data

USD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -179.8 -93.0 -333.6 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.9 0.1 -0.6 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -72.6 -16.2 -116.1 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 8.3 4.7 0.9 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 7.4 3.6 0.5 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 81.6 58.7 21.1 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -639.4 -795.8 -284.1 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 4.4 7.5 2.4 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.9 1.0 0.9 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.1 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 101.8 32.5 332.5 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.1 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.1 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -2,834.0 -2,127.0 -3,675.6 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -73.5 -126.7 -272.3 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -73.5 -126.7 -272.3 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 1.8 -1.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -85.3 -226.1 265.7 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -85.3 -226.1 265.7 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 398.0 373.1 407.3 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 82.5 48.9 149.6 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 480.5 422.0 556.9 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 98.3 76.0 368.8 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 382.2 346.0 188.2 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IMR Shortsell

Frequently Asked Questions

The current share price of Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) is AU$1.02.
The 52-week high share price for Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) is AU$1.38.
The 52-week low share price for Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX)? is AU$0.41.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) does not pay a dividend.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) does not pay a dividend.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) has a franking level of 0.0%.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) is classified in the Healthcare.
The current P/E ratio for Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.